Sort   by:  
 Page size 
UnknownA comprehensive assessment of resting state networks: bidirectional modification of functional integrity in cerebro-cerebellar networks in dementia.
Not available
S-EPMC4115623 | biostudies-literature
UnknownExploring Patterns of Alteration in Alzheimer's Disease Brain Networks: A Combined Structural and Functional Connectomics Analysis.
Not available
S-EPMC5013043 | biostudies-literature
UnknownLongitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis.
Not available
S-EPMC5839599 | biostudies-literature
UnknownCerebellar lobules and dentate nuclei mirror cortical force-related-BOLD responses: Beyond all (linear) expectations.
Not available
S-EPMC5413835 | biostudies-literature
UnknownContralateral cerebello-thalamo-cortical pathways with prominent involvement of associative areas in humans in vivo.
Not available
S-EPMC4575696 | biostudies-literature
UnknownDevelopment, content and planned evaluation of a behavioural support intervention to reduce ultraprocessed food intake and increase physical activity in UK healthcare workers: UPDATE trial stage 2 study protocol.
Not available
S-EPMC12574385 | biostudies-literature
UnknownProgression of regional grey matter atrophy in multiple sclerosis.
Not available
S-EPMC5995197 | biostudies-literature
UnknownMultiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.
Not available
S-EPMC6119433 | biostudies-literature
UnknownInvestigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trial.
Not available
S-EPMC11422291 | biostudies-literature
UnknownEfficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial.
Not available
S-EPMC7029307 | biostudies-literature
Sort   by:  
 Page size